Muriel O’Byrne

Senior Vice President, International Regulatory Affairs and Head, European Business Office · Regeneron Pharmaceuticals

Biopharmaceuticals

Muriel O’Byrne is senior vice president of international regulatory affairs and head of the European Business Office at Regeneron Pharmaceuticals. She joined in 2014 after regulatory leadership at Elan, AstraZeneca and GSK.

Last reviewed: Oct 21, 2026

Muriel O’Byrne

Senior Vice President, International Regulatory Affairs and Head, European Business Office Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Muriel O’Byrne is senior vice president of international regulatory affairs and head of the European Business Office at Regeneron Pharmaceuticals. She joined in 2014 after regulatory leadership at Elan, AstraZeneca and GSK.

Career Highlights

  • Joined Regeneron in 2014.
  • Leads international regulatory affairs and the European Business Office in Dublin.
  • Previously held regulatory affairs roles at Elan, AstraZeneca and GSK.

Professional Journey

O’Byrne developed her regulatory affairs career at Elan Pharmaceuticals, AstraZeneca and GSK, holding positions of increasing responsibility. Her experience includes global regulatory strategies across product development and commercialization and building regulatory functions.

She joined Regeneron in 2014. Her team works with international regulatory authorities, including those in the European Economic Area and Japan, communicating the company’s scientific and product information to regulators.

She also heads the European Business Office in Dublin. The combined remit links international regulatory engagement with leadership of that office, drawing on more than twenty-five years of industry experience described in her current company biography.

Education

O’Byrne earned a BSc with honours from University College Cork, National University of Ireland, and a doctorate from Trinity College Dublin.